Mounjaro Makes Me Constipated — Here's Why, and What You Can Do

Constipation is one of the recognised gastrointestinal side effects of tirzepatide, listed in the patient information leaflet and reported in clinical trials.
It tends to be most noticeable after starting treatment or after a dose increase, and often eases as your body adjusts.
Severe or persistent abdominal pain (especially pain that radiates to your back) is different from ordinary constipation and needs urgent medical attention.
You can report any suspected side effect from Mounjaro through the MHRA's Yellow Card scheme, which helps monitor medicine safety across the UK.

Constipation on Mounjaro is common, and usually temporary. Tirzepatide slows the movement of food through your digestive system, which means your gut has more time to absorb water from stools — the very mechanism that causes constipation for a significant number of people starting or increasing their dose. It is a prescription-only medicine, so any changes to how you manage side effects should be discussed with your prescriber. Most people find the discomfort settles within a few weeks, and there are practical steps that genuinely help in the meantime.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The reality of constipation on Mounjaro, and what the evidence actually says

The myth: constipation means Mounjaro isn't working, or that something is wrong

A question our prescribers hear most weeks is whether constipation is a sign that something has gone badly wrong. It isn't. It is one of the most predictable responses to a medicine that deliberately slows gastric emptying. Tirzepatide activates both GIP and GLP-1 receptors, which reduces appetite and helps regulate blood sugar, but that same slowing of digestion also gives the large intestine more time to pull water from whatever is passing through. The result, for many people, is harder, less frequent stools.

The NHS medicines page for tirzepatide lists constipation as a common side effect. It appeared in the SURMOUNT-1 trial data alongside the more talked-about nausea. Importantly, it does not indicate that the medicine is failing you, that your dose is wrong, or that you need to stop. It is biology doing exactly what the pharmacology predicts.

Where constipation does become a concern is when it arrives alongside severe stomach pain, particularly pain that spreads toward the back. That pattern can point to something other than ordinary sluggish digestion, and it needs same-day medical assessment. More on that below.

Why it gets worse after a dose increase, and why that's normal

If you sailed through the 2.5 mg starting period and then hit a wall of constipation at 5 mg or beyond, you are not unusual. Each step up the dosing schedule intensifies the gut-slowing effect, at least temporarily. Your digestive system has to recalibrate, and that process takes time, often one to three weeks, though it varies considerably between people.

Hydration matters more than people realise at this point. When your gut moves more slowly, drinking enough water is the single most effective buffer against hard stools. Many people on tirzepatide also eat considerably less than before, which can mean less fibre if they are not paying attention to what they do eat. Protein tends to crowd out vegetables in smaller meals; keeping some soluble fibre in (oats, lentils, cooked vegetables) makes a real difference.

Gentle physical activity helps too. Even a short walk after eating stimulates gut motility in ways that sitting still does not. If constipation is severe or prolonged, your prescriber may suggest an over-the-counter osmotic laxative; do not assume any laxative is fine without checking, as stimulant laxatives in particular are not always appropriate alongside GLP-1 medicines. Our detailed guide to constipation on Mounjaro covers practical management options in full.

When constipation stops being a nuisance and becomes a warning sign

Ordinary constipation on tirzepatide is uncomfortable but not dangerous. There are specific symptoms, though, that change the picture.

Seek urgent medical help if you experience severe abdominal pain that does not ease, especially if it radiates to your back or is accompanied by vomiting. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis, an uncommon but serious condition. Pancreatitis does not feel like constipation; it is a different quality of pain, persistent and often severe. If in doubt, call NHS 111 or go to A&E.

Similarly, if you have not had a bowel movement for more than a week, or if you notice blood, get advice the same day. Prolonged constipation can occasionally lead to complications that are much easier to treat early. You can also read about the broader side-effect profile of Mounjaro to understand where constipation fits alongside other GI symptoms like nausea, which we cover separately on the Mounjaro nausea page.

How your prescriber fits into this

Side effects like constipation are a routine part of the clinical conversation, not an embarrassing admission. If what you are experiencing feels unmanageable, or if you are considering slowing your titration to give your gut more time, your prescriber is the right person to talk to, not a forum. Adjusting pace is a clinically led decision.

At nume, every repeat order goes through a fresh clinical review before anything is dispensed. That means your prescriber sees how you are getting on, not just whether your BMI has changed. If you find yourself constipated on Mounjaro and it is affecting how you are tolerating treatment, that is relevant clinical information your prescriber needs to know. You can reach the aftercare team seven days a week via the contact page.

If you are not yet on treatment and side effects like this are part of what you are weighing up, you can check your eligibility through a free consultation, our prescribers go through suitability and the likely side-effect picture as a normal part of the process. You can also read more about Mounjaro as a treatment or explore why constipation on tirzepatide can be more stubborn than expected before you decide.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions